Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Innovative Diagnostic Laboratory

Innovative Diagnostic Laboratory
2013 FOUNDED
M&A STATUS
21-30 EMPLOYEES
M&A LATEST DEAL TYPE
3 FINANCING ROUNDS
Description

Provider of personalized blood-based testing services intended to help find, understand and address cancer risk in patient populations. The company offers traditional and advanced clinical evidence-based blood tests that aid in cancer risk stratification and risk assessment blood tests for the three cancer types including lung, colon, and prostate.

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Laboratory Services (Healthcare)
Parent Company
Primary Office
  • 8751 Park Central Drive
  • Suite 200
  • Richmond, VA 23227
  • United States

+1 (855) 000-0000

Innovative Diagnostic Laboratory Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Innovative Diagnostic Laboratory‘s full profile, request access.

Request full access to PitchBook

Innovative Diagnostic Laboratory Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Innovative Diagnostic Laboratory‘s full profile, request access.

Request full access to PitchBook

Innovative Diagnostic Laboratory Executive Team (6)

Name Title Board
Seat
Contact
Info
Joanna Halsey JD Chief Compliance Officer & General Counsel
Eric Mayton Operations Manager
Joel Brill MD Chief Medical Officer
James Howard-Tripp Chief Executive Officer
Leslie Auld Chief Financial Officer

1 Former Executive

You’re viewing 5 of 6 executives. Get the full list »